Key Takeaways
- Shares of RKLB have declined approximately 30% since peaking in late May, now hovering near $107.98
- First quarter revenue reached an all-time high of $200.35 million, representing a 63.4% increase year-over-year and surpassing analyst projections
- The company is set to enter the Nasdaq-100 index on June 22, potentially attracting increased institutional investment
- Institutional investors control 71.78% of shares, with Capital Impact Advisors recently boosting its position by 47.5%
- Analysts maintain an average price target of $102.76 with a “Moderate Buy” consensus recommendation
The aerospace company has experienced significant pressure following SpaceX’s high-profile market debut, watching RKLB shares retreat nearly 30% from late-May peaks around $151.00. Trading commenced Thursday at $107.98, maintaining a position above the 50-day moving average of $104.00 while remaining substantially below recent highs.
The stock decline contrasts sharply with operational performance. First quarter revenues reached $200.35 million, establishing a new quarterly benchmark while climbing 63.4% compared to the prior year period. This figure exceeded Wall Street’s consensus forecast of $189.65 million.
Profitability metrics also showed meaningful improvement, with gross margins reaching a company record of 38.2% during Q1. This trend indicates strengthening unit economics as operations expand. The current order backlog stands at $2.2 billion, providing substantial revenue visibility for upcoming quarters.
Executives have projected another record-setting quarter for Q2, extending a pattern that indicates Rocket Lab is experiencing sustained growth momentum rather than temporary strength.
Government Contracts Expanding Revenue Streams
The company’s business model is evolving beyond traditional launch operations. In 2024, Rocket Lab secured a substantial $515 million contract from the Space Development Agency to manufacture satellites, establishing its position as a primary contractor for U.S. government projects.
Additionally, a $30 million agreement with Anduril Industries will utilize the company’s HASTE platform for hypersonic testing missions launched from Virginia’s Launch Complex 2. These government partnerships are diversifying income sources beyond the commercial small-satellite launch market.
Rocket Lab’s Electron launch vehicle maintains its status as the most frequently deployed small rocket globally, executing 10–15 missions annually. Its closest competitor in this market segment is China’s Galactic Energy with the Ceres-1 rocket.
In a recent announcement, the firm revealed its largest pre-booking agreement to date — five Neutron launches committed before the vehicle’s maiden flight.
Index Addition and Shareholder Activity
The scheduled June 22 addition to the Nasdaq-100 represents a potentially significant catalyst. Index membership typically generates automatic purchasing from passive investment vehicles that track the benchmark.
Capital Impact Advisors expanded its holdings by 47.5% during the fourth quarter, purchasing an additional 145,741 shares to reach a total position of 452,728 units. Institutional investors collectively hold 71.78% of outstanding shares.
Regarding insider transactions, Senior Vice President Arjun Kampani divested 23,804 shares at $147.43 on May 28, while insider Marvin Bradford Clevenger sold 3,500 units at $146.67 on the same date. Total insider sales have reached $66.9 million during the past 90 days.
Valuation metrics present challenges for the stock. RKLB currently trades at approximately 68 times forward price-to-sales, exceeding the sector median by more than 3,500%. Such elevated multiples typically apply to high-margin technology companies rather than hardware manufacturers operating with 38% gross margins.
The Neutron rocket, a medium-payload vehicle central to much of the company’s valuation thesis, has yet to complete its inaugural flight. A setback during propellant tank testing has delayed the first launch to Q4 2026, maintaining execution uncertainty.
Following first quarter results, TD Cowen and Needham both elevated their price targets to $120 while maintaining Buy recommendations. KGI Securities launched coverage on June 11 with a Neutral rating and $105 target. The analyst consensus price target averages $102.76.
